DHEA-S (Dehydroepiandrosterone Sulfate) Blood Test

What Does This Test Measure?

DHEA-S is an androgen precursor produced primarily by the adrenal glands. It is the most abundant circulating steroid hormone. DHEA-S levels decline steadily with age (adrenopause). DHEA-S is useful for evaluating adrenal androgen excess and for assessing adrenal function.

Why Your Doctor Ordered This Test

DHEA-S is ordered when a healthcare provider suspects an adrenal androgen excess disorder. The classic scenario is a woman presenting with hirsutism, severe acne, male-pattern hair loss, or menstrual irregularities that suggest hyperandrogenism. In these cases, DHEA-S helps differentiate between an adrenal source (elevated DHEA-S with normal ovarian androgens) and an ovarian source (e.g., PCOS, where testosterone and androstenedione are often more prominent, though DHEA-S can be mildly elevated). The test is also a key first step in the workup of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, where deficient cortisol production leads to ACTH-driven adrenal overproduction of androgens, markedly raising DHEA-S. For adrenal masses found incidentally on imaging, a DHEA-S level above 600–700 µg/dL raises concern for an androgen-secreting adrenal adenoma or carcinoma.

Additionally, DHEA-S is measured when evaluating adrenal insufficiency, particularly in younger adults where a very low DHEA-S can be an early clue before standard cortisol testing shows overt deficiency. In the context of fatigue, weight loss, and low blood pressure, a low DHEA-S (often below age- and sex-adjusted norms) prompts an ACTH stimulation test to confirm primary or secondary adrenal insufficiency. The test is also used to monitor glucocorticoid therapy; exogenous steroids suppress ACTH, which in turn lowers DHEA-S, and a suppressed value can confirm adequate adrenal suppression. Rarely, DHEA-S is checked in premature adrenarche (the early appearance of pubic hair before age 8 in girls or age 9 in boys) where mild elevation can distinguish benign premature adrenarche from pathologic conditions.

What High DHEA-S Means

High DHEA-S: adrenal androgen excess, congenital adrenal hyperplasia (21-hydroxylase deficiency, the most common form), adrenal tumors (adenoma or carcinoma, very high DHEA-S, often >600–700 µg/dL), and PCOS (mild-to-moderate elevation). In women, high DHEA-S causes hirsutism, acne, and irregular periods.

What Low DHEA-S Means

Low DHEA-S: normal aging (adrenopause, DHEA-S declines ~2–5% per year after age 30), adrenal insufficiency (primary or secondary), corticosteroid therapy (suppresses ACTH), and severe illness (acute or chronic). Low DHEA-S in a younger person may suggest adrenal insufficiency and warrants further testing (ACTH stimulation test).

How to Prepare and What Affects the Result

Most laboratories do not require fasting for a DHEA-S blood draw, but consistent timing is important because DHEA-S shows a mild diurnal variation; levels are slightly higher in the morning. For this reason, it is usually drawn between 7 a.m. and 9 a.m. along with morning cortisol and ACTH if a full adrenal workup is performed. Biotin (vitamin B7) supplements can interfere with the immunoassays used to measure DHEA-S, causing falsely high results in some assay platforms; patients should stop biotin for at least 48–72 hours before the test. Oral contraceptives and estrogen therapy increase sex hormone binding globulin (SHBG) and can modestly alter DHEA-S metabolism, but the net effect on measured DHEA-S is usually small; nevertheless, the lab order should note any hormonal medications. Glucocorticoids, including prednisone and dexamethasone, suppress ACTH and will lower DHEA-S, while drugs that induce CYP3A4 (such as phenytoin, rifampin) may accelerate DHEA-S clearance and reduce levels.

Sample handling is straightforward: serum is collected in a red-top or serum separator tube, and the sample is stable at room temperature for several days, but laboratories often freeze aliquots if testing is delayed. Hemolysis and lipemia do not typically interfere with modern chemiluminescent immunoassays. Because DHEA-S concentrations vary significantly with age and sex, the requisition form must include the patient’s age and sex to ensure the correct reference interval is applied. If an ACTH stimulation test is planned for adrenal insufficiency workup, the DHEA-S sample should be collected before synthetic ACTH is administered, as the stimulation test does not affect DHEA-S levels acutely but is part of the same diagnostic sequence.

Common Misinterpretations

One common misinterpretation is equating a mildly elevated DHEA-S with an adrenal tumor, when in fact mild elevations (up to ~600 µg/dL in young women) are frequently seen in PCOS and represent polycystic ovarian/adrenal hyperandrogenism, not neoplasia. The DHEA-S concentration in PCOS rarely exceeds 700 µg/dL, and in true adrenal carcinoma, levels are often well above 700 µg/dL, accompanied by rapid symptom progression and an adrenal mass on imaging. Another frequent error is interpreting an age-related decline in DHEA-S as adrenal insufficiency. DHEA-S falls by 2–5% per year after age 30, so a 55-year-old with a DHEA-S of 40 µg/dL may be entirely normal for age, but this value could be flagged as "low" if the laboratory uses a broad adult reference range that does not account for midlife decline. Without age-adjusted ranges, healthy older adults may be incorrectly labeled as having hypoadrenalism.

Interpreting DHEA-S in women taking oral contraceptives also causes confusion. Estrogens in contraceptives reduce androgen production via suppression of LH, which can lower ovarian androgen output, but DHEA-S is predominantly adrenal and not directly influenced by LH; however, contraceptives can lower DHEA-S modestly through uncertain mechanisms, leading to a borderline-low result that should not be mistaken for adrenal insufficiency. A truly low DHEA-S due to adrenal failure is usually accompanied by other clues, low cortisol, high ACTH, and symptoms like salt craving and hyperpigmentation. Additionally, measuring DHEA-S in isolation without simultaneous cortisol and ACTH can mislead; a high DHEA-S with a low cortisol and elevated ACTH points to CAH, while high DHEA-S with high cortisol and suppressed ACTH suggests an adrenal tumor. Without these parallel measurements, the source of androgen excess remains unclear, and a DHEA-S result alone cannot pinpoint the pathology.

Frequently Asked Questions

What does a high DHEA-S level mean in women?

A high DHEA-S in women typically points to adrenal androgen excess. It can signify congenital adrenal hyperplasia (most commonly 21-hydroxylase deficiency), an androgen-secreting adrenal tumor (adenoma or carcinoma), or polycystic ovary syndrome (PCOS). In PCOS, DHEA-S is often mildly elevated, while in adrenal tumors levels may exceed 700 µg/dL. The clinical picture (hirsutism, acne, menstrual disturbances) and additional labs like testosterone, androstenedione, and ACTH help distinguish the cause.

What causes low DHEA-S?

Low DHEA-S can result from normal aging (adrenopause), where levels fall 2–5% per year after age 30. Pathologic causes include primary adrenal insufficiency (Addison's disease), secondary adrenal insufficiency due to pituitary failure, or prolonged glucocorticoid therapy that suppresses ACTH. Severe illness, malnutrition, and certain medications like opioids can also lower DHEA-S. In younger adults, a significantly low DHEA-S for age warrants further evaluation with an ACTH stimulation test and morning cortisol.

Do I need to fast for a DHEA-S blood test?

Fasting is not required for a DHEA-S test, but early-morning collection (7–9 a.m.) is recommended because DHEA-S exhibits a mild diurnal rhythm with peak levels in the morning. If your doctor orders a full adrenal panel including cortisol and ACTH, fasting may be required for other components like glucose. Inform your provider about biotin supplements, oral contraceptives, and glucocorticoid medications, as these can affect the result. Your laboratory will provide specific pre-test instructions.

Can DHEA-S levels indicate adrenal cancer?

Yes, markedly elevated DHEA-S, often exceeding 700 µg/dL, can indicate an androgen-secreting adrenal carcinoma or a large adrenal adenoma. DHEA-S levels above 600–700 µg/dL raise suspicion, especially when accompanied by rapid-onset virilization (deepening voice, clitoromegaly), and an adrenal mass on CT or MRI. However, PCOS can also produce high DHEA-S, though rarely above 700 µg/dL. Confirmatory testing includes imaging and additional hormone levels like androstenedione, cortisol, and ACTH to determine if the mass is functional and whether it is malignant.

How does DHEA-S differ from DHEA?

DHEA (dehydroepiandrosterone) and DHEA-S (dehydroepiandrosterone sulfate) are closely related but differ in stability and measurement. DHEA is the unsulfated form with a short half-life and pronounced diurnal variation, making it less practical for routine testing. DHEA-S is the sulfated storage form, circulates at much higher concentrations, has a long half-life of 10–20 hours, and shows minimal diurnal fluctuation, so it is the preferred marker for assessing adrenal androgen production. Labs measure DHEA-S by immunoassay, and results correlate with total androgen load.

Related Markers: Read Together for Full Context

BloodWorker reads lab values together, not in isolation. These related markers provide essential context for interpreting your DHEA-S result: